Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micronutrient Supplementation in Children with ASD
NCT05268744Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Nov 2022
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in Autism Spectrum Disorder (ASD), sponsored by University of California, San Francisco. Primary endpoints: Autism Behavior Inventory, Short Form at 8 weeks and Social Responsiveness Scale at 8 weeks. Started Nov 2022; status: completed.
02
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05268744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05268744.